Anti-PINK1 antibody [MJF-R32-7]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(15 Publications)
Rabbit Recombinant Monoclonal PINK1 antibody. Suitable for WB and reacts with Human samples. Cited in 15 publications.
View Alternative Names
BRPK, PTEN-induced putative kinase protein 1, PINK1
- WB
Lab
Western blot - Anti-PINK1 antibody [MJF-R32-7] (AB300623)
Western blot : Anti-PINK1 antibody [MJF-R32-7] (ab300623) staining at 1/1000 dilution, shown in black; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in magenta.
In Western blot, ab300623 was shown to bind specifically to PINK1. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times before development with a high-sensitivity ECL substrate kit and imaged with 20 minutes exposure time. Secondary antibodies used were HRP conjugated Goat anti-Rabbit (H+L) and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
In Western blot, ab300623 was shown to bind specifically to PINK1. A band was observed at 63kDa in wild-type SH-SY5Y treated with CCCP cell lysates with no signal observed at this size in PINK1 knockout cell line (ab280876).
All lanes:
Western blot - Anti-PINK1 antibody [MJF-R32-7] (ab300623)
Lane 1:
Wild-type SH-SY5Y treated CCCP, <a href='/en-us/products/biochemicals/cccp-mitochondrial-oxidative-phosphorylation-uncoupler-ab141229'>ab141229</a> (10 μM, 24 h) cell lysate at 20 µg
Lane 2:
Wild-type SH-SY5Y control CCCP (0 μM, 24 h) cell lysate at 20 µg
Lane 3:
PINK1 knockout SH-SY5Y (<a href='/en-us/products/cell-lines/human-pink1-knockout-sh-sy5y-cell-line-ab280876'>ab280876</a>) treated CCCP, <a href='/en-us/products/biochemicals/cccp-mitochondrial-oxidative-phosphorylation-uncoupler-ab141229'>ab141229</a> (10 uM, 24 h) cell lysate at 20 µg
Lane 4:
Western blot - Human PINK1 knockout SH-SY5Y cell line (<a href='/en-us/products/cell-lines/human-pink1-knockout-sh-sy5y-cell-line-ab280876'>ab280876</a>) at 20 µg
Lane 5:
Wild-type HEK-293 Treated CCCP, <a href='/en-us/products/biochemicals/cccp-mitochondrial-oxidative-phosphorylation-uncoupler-ab141229'>ab141229</a> (10 μM, 24 h) cell lysate at 20 µg
Lane 6:
PINK1 knockout HEK-293 Treated CCCP, <a href='/en-us/products/biochemicals/cccp-mitochondrial-oxidative-phosphorylation-uncoupler-ab141229'>ab141229</a> (10 μM, 24 h) cell lysate at 20 µg
Secondary
All lanes:
HRP conjugated Goat anti-Rabbit (H+L) and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Predicted band size: 63 kDa
Observed band size: 63 kDa
true
- WB
Supplier Data
Western blot - Anti-PINK1 antibody [MJF-R32-7] (AB300623)
Anti-PINK1 antibody [MJF-R32-7] (ab300623) staining at 1/1000 dilution, shown in black; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. ab300623 was shown to bind specifically to PINK1. A band was observed at 60 kDa in wild-type HEK-293 cell lysates with no signal observed at this size in PINK1 knockout cell line ab266393 (knockout cell lysate ab257030). To generate this image, wild-type and PINK1 knockout HEK-293 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times before development with Optiblot (ECL reagent ab133456) and imaged with 4 minutes exposure time. Secondary antibodies used were HRP conjugated Goat anti-Rabbit (H+L) and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-PINK1 antibody [MJF-R32-7] (ab300623) at 1/1000 dilution
Lane 1:
Wild-type HEK-293 Vehicle Control CCCP, <a href='/en-us/products/biochemicals/cccp-mitochondrial-oxidative-phosphorylation-uncoupler-ab141229'>ab141229</a> (0 µM, 24 h) cell lysate at 20 µg
Lane 2:
Wild-type HEK-293 Treated CCCP, <a href='/en-us/products/biochemicals/cccp-mitochondrial-oxidative-phosphorylation-uncoupler-ab141229'>ab141229</a> (10 µM, 24 h) cell lysate at 20 µg
Lane 3:
PINK1 knockout HEK-293 Vehicle Control CCCP, <a href='/en-us/products/biochemicals/cccp-mitochondrial-oxidative-phosphorylation-uncoupler-ab141229'>ab141229</a> (0 µM, 24 h) cell lysate at 20 µg
Lanes 3 - 4:
Western blot - Human PINK1 knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-pink1-knockout-hek-293t-cell-line-ab266393'>ab266393</a>)
Lane 4:
PINK1 knockout HEK-293 Treated CCCP, <a href='/en-us/products/biochemicals/cccp-mitochondrial-oxidative-phosphorylation-uncoupler-ab141229'>ab141229</a> (10 µM, 24 h) cell lysate at 20 µg
Secondary
All lanes:
HRP conjugated Goat anti-Rabbit (H+L) and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Predicted band size: 63 kDa
false
- WB
Supplier Data
Western blot - Anti-PINK1 antibody [MJF-R32-7] (AB300623)
All lanes:
Western blot - Anti-PINK1 antibody [MJF-R32-7] (ab300623) at 1/1000 dilution
All lanes:
Rat testis tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
false
Related conjugates and formulations (1)
-
Anti-PINK1 antibody [MJF-R32-7] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Collaborations
This antibody was developed with support from The Michael J. Fox Foundation.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The PINK1 protein detects mitochondrial damage and recruits Parkin an E3 ubiquitin ligase to the damaged mitochondria. This interaction leads to the ubiquitylation of mitochondrial substrates and triggers their degradation. PINK1 Parkin and other proteins form a complex that facilitates the removal of damaged mitochondria through autophagy. This mechanism ensures cellular health and energy balance by maintaining a pool of functional mitochondria.
Pathways
PINK1 integrates into the mitochondrial quality control and mitophagy pathways. It has a fundamental role in the PINK1-Parkin pathway which is critical for maintaining mitochondrial integrity. In this pathway PINK1 phosphorylates both ubiquitin and Parkin enhancing Parkin’s E3 ligase activity. Another pathway that PINK1 participates in is the PTEN-induced kinase pathway where it regulates mitochondrial dynamics and homeostasis via cross-talk with other mitochondrial proteins such as DJ-1 and LRRK2.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (15)
Recent publications for all applications. Explore the full list and refine your search
Oncology research 33:2421-2434 PubMed40918465
2025
Applications
Unspecified application
Species
Unspecified reactive species
Histology and histopathology :18958 PubMed40654025
2025
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceuticals (Basel, Switzerland) 17: PubMed39770569
2025
Applications
Unspecified application
Species
Unspecified reactive species
CNS neuroscience & therapeutics 30:e14878 PubMed39097923
2024
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 27:147 PubMed38476889
2024
Applications
WB
Species
Human
Acta biochimica et biophysica Sinica 56:356-365 PubMed38419499
2024
Applications
WB
Species
Human
Journal of ethnopharmacology 325:117766 PubMed38266949
2024
Applications
WB
Species
Rat
Journal of ovarian research 17:12 PubMed38200521
2024
Applications
WB
Species
Mouse
Heliyon 10:e23077 PubMed38163129
2024
Applications
WB
Species
Rat
Acta biochimica Polonica 70:533-539 PubMed37672716
2023
Applications
WB
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com